blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP0754033

EP0754033 - HETEROFUNCTIONAL, MUCOADHESIVE DOSAGE FORM [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  01.09.2000
Database last updated on 02.09.2024
Most recent event   Tooltip04.01.2008Lapse of the patent in a contracting state
New state(s): IT		published on 06.02.2008  [2008/06]
Applicant(s)For all designated states
Biotec Centre S.A.
12, avenue de Concyr
45071 Orléans Cédex 2 / FR
[1997/04]
Inventor(s)01 / BROMET, Norbert Emile
L'Orée-de-Sologne 3, rue Gustave-Flaubert
F-45100 Orléans-la-Source / FR
[1997/04]
Representative(s)Desaix, Anne
Ernest Gutmann - Yves Plasseraud S.A.S.
66, rue de la Chaussée d'Antin
75009 Paris / FR
[N/P]
Former [1997/04]Desaix, Anne
Ernest Gutmann - Yves Plasseraud S.A. 3, rue Chauveau-Lagarde
75008 Paris / FR
Application number, filing date95916694.331.03.1995
[1997/04]
WO1995FR00417
Priority number, dateFR1994000389501.04.1994         Original published format: FR 9403895
[1997/04]
Filing languageFR
Procedural languageFR
PublicationType: A1 Application with search report
No.:WO9526713
Date:12.10.1995
Language:FR
[1995/43]
Type: A1 Application with search report 
No.:EP0754033
Date:22.01.1997
Language:FR
The application published by WIPO in one of the EPO official languages on 12.10.1995 takes the place of the publication of the European patent application.
[1997/04]
Type: B1 Patent specification 
No.:EP0754033
Date:03.11.1999
Language:FR
[1999/44]
Search report(s)International search report - published on:EP12.10.1995
ClassificationIPC:A61K9/24, A61K31/40
[1997/04]
CPC:
A61K9/209 (EP,US); A61K31/40 (EP,US); A61K9/006 (EP,US);
A61P25/20 (EP); A61P25/22 (EP); A61P25/24 (EP);
A61P25/26 (EP); A61P35/00 (EP); A61P43/00 (EP) (-)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [1997/04]
TitleGerman:HETEROFUNKTIONELLE MUCOADHÄSIVE GALENISCHE ZUSAMMENSETZUNG[1997/04]
English:HETEROFUNCTIONAL, MUCOADHESIVE DOSAGE FORM[1997/04]
French:COMPOSITION GALENIQUE MUCOADHESIVE HETEROFONCTIONNELLE[1997/04]
Entry into regional phase30.09.1996National basic fee paid 
30.09.1996Designation fee(s) paid 
30.09.1996Examination fee paid 
Examination procedure26.10.1995Request for preliminary examination filed
International Preliminary Examining Authority: EP
30.09.1996Examination requested  [1997/04]
11.03.1998Despatch of a communication from the examining division (Time limit: M04)
07.07.1998Reply to a communication from the examining division
14.01.1999Despatch of communication of intention to grant (Approval: Yes)
23.04.1999Communication of intention to grant the patent
16.07.1999Fee for grant paid
16.07.1999Fee for publishing/printing paid
Opposition(s)04.08.2000No opposition filed within time limit [2000/42]
Fees paidRenewal fee
21.05.1997Renewal fee patent year 03
24.03.1998Renewal fee patent year 04
29.03.1999Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.03.199703   M06   Fee paid on   21.05.1997
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT03.11.1999
ES03.11.1999
GR03.11.1999
IE03.11.1999
IT03.11.1999
NL03.11.1999
SE03.11.1999
DK03.02.2000
PT03.02.2000
DE04.02.2000
BE31.03.2000
LU31.03.2000
[2008/06]
Former [2007/29]AT03.11.1999
ES03.11.1999
GR03.11.1999
IE03.11.1999
NL03.11.1999
SE03.11.1999
DK03.02.2000
PT03.02.2000
DE04.02.2000
BE31.03.2000
LU31.03.2000
Former [2004/07]AT03.11.1999
ES03.11.1999
GR03.11.1999
IE03.11.1999
NL03.11.1999
SE03.11.1999
DK03.02.2000
PT03.02.2000
DE04.02.2000
BE31.03.2000
Former [2003/45]AT03.11.1999
ES03.11.1999
IE03.11.1999
NL03.11.1999
SE03.11.1999
DK03.02.2000
PT03.02.2000
DE04.02.2000
BE31.03.2000
Former [2003/17]AT03.11.1999
ES03.11.1999
IE03.11.1999
NL03.11.1999
SE03.11.1999
PT03.02.2000
DE04.02.2000
BE31.03.2000
MC31.03.2000
Former [2003/08]AT03.11.1999
ES03.11.1999
IE03.11.1999
NL03.11.1999
SE03.11.1999
PT03.02.2000
DE04.02.2000
BE31.03.2000
Former [2002/26]AT03.11.1999
ES03.11.1999
IE03.11.1999
SE03.11.1999
PT03.02.2000
DE04.02.2000
BE31.03.2000
Former [2002/23]AT03.11.1999
IE03.11.1999
SE03.11.1999
PT03.02.2000
DE04.02.2000
BE31.03.2000
Former [2002/22]AT03.11.1999
IE03.11.1999
PT03.02.2000
DE04.02.2000
BE31.03.2000
Former [2002/09]AT03.11.1999
PT03.02.2000
DE04.02.2000
BE31.03.2000
Former [2001/17]AT03.11.1999
IE03.11.1999
PT03.02.2000
BE31.03.2000
Former [2001/11]AT03.11.1999
PT03.02.2000
BE31.03.2000
Former [2000/51]AT03.11.1999
PT03.02.2000
Former [2000/43]PT03.02.2000
Cited inInternational search[A]EP0020777  (TEIJIN LTD [JP]) [A] 1-13 * page 2, line 26 - line 36 * * page 4, line 5 - line 28 * * page 6, line 18 - line 35 * * page 9, line 20 * * page 10, line 2 - page 12 *;
 [A]US4250163  (IKURA HIROSHI [JP], et al) [A] 1 * column W *;
 [A]EP0159604  (TOYO BOSEKI [JP]) [A] 1-13 * page 2, line 23 - page 10, line 14 * * page 38, line 22 - page 42, line 14 * * figures 13-16 *;
 [A]WO8704342  (KEY PHARMA [US]) [A] 1 * the whole document *;
 [AD]WO9106290  (RIKER LABORATORIES INC [US]) [AD] 1-13 * page 44; example 64 *;
 [AD]EP0518468  (NEURIM PHARMA 1991 [IL]) [AD] 10-13* page 2, line 49 - page 3, line 12 *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.